Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersNeurology Physician in Houston, TX
NPI: 1013133768Primary Practice Location
HOUSTON METHODIST HOSPITAL
6565 Fannin St, Houston, TX
Primary Employer
Tmh Physician Associates PLLC
houstonmethodist.org
HQ Phone
Get M.D. Olga's Phone Numberphone_androidMobile
Get M.D. Olga's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
2012 - 2026
MI State Medical License
2011 - 2015
American Board of Psychiatry and Neurology
Neurology
University of Tennessee
Residency • Neurology
2008 - 2011
Internship • Internal Medicine
2007 - 2008
Vitebsk State Medical University
Medical School
Until 1997
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 246 | 536 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 59 | 78 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 50 | 138 |
| 4 | J0585Injection, onabotulinumtoxina, 1 unit | 43 | 28,500 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 43 | 43 |
Authors: Waln, Olga, Ledoux, Mark S
Journal: Tremor Other Hyperkinet Mov (N Y)
'Rechargeable deep brain stimulation implantable pulse generators in movement
Authors: Waln, Olga, Jimenez-Shahed, Joohi
Journal: Neuromodulation
Publication Date: 2013-09-24
Genotype-phenotype relations for episodic ataxia genes: MDSGene systematic review.
Lead Sponsor: Jazz Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: CX-8998
Lead Sponsor: Theranexus
Intervention / Treatment: DRUG: THN102 Dosage A, DRUG: THN102 Dosage B, DRUG: THN102 Dosage C
Lead Sponsor: ACADIA Pharmaceuticals Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Pimavanserin 20 mg, DRUG: Pimavanserin 34 mg
